Dr. Luis E. Raez, MD, FACP, FCCP

Expert Publications

• Pulmonary bone marrow embolism in sickle cell disease.
• Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
• Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells.
• Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma.
• Irinotecan and docetaxel as first line chemotherapy in patients with stage
• Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer.
• Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
• Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer.
• Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.
• DNA methylation: its role in lung carcinogenesis and therapeutic implications.
• Chemotherapy for advanced non-small-cell lung cancer.
• Lung cancer immunotherapy.
• Pemetrexed-associated urticarial vasculitis.
• New developments in chemotherapy for advanced non-small cell lung cancer.
• Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.

Clinical Trials

• Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients

Media Releases

Get to know Hematology-Oncologist Dr. Luis E. Raez, who serves the population of Pembroke Pines, Florida. Dr. Raez graduated from Facultad De Medicina De La Univ Peruana Cayetano in Peru where he received his completed his Medical Degree in 1992, giving him over two decades of experience in his field. After obtaining his Medical Degree he then completed his internal medicine internship and residency with the Jackson Memorial Hospital. Wanting to further his training he then completed his Oncology and Hematology fellowship with Jackson Memorial Hospital. He is dual certified in internal medicine and medical oncology from the American Board of Internal Medicine. Dr. Raez currently practices with the Memorial Healthcare System. A hematologist-oncologist who is a physician who specializes in the diagnosis, treatment and/or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. They will be trained in hematology, the study of blood and oncology, the study of cancer, but will specialize in treating blood cancers, such as Hodgkins and non-Hodgkins lymphomas, leukemias and multiple myelomas. A hematologist-oncologist may also specialize in the management of solid tumors.

Recommended Articles

• Multiple Myeloma: What is Autotransplantation?

  During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...

• Potential Causes of Leukopenia

  IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...

• Teen Finds Strength to Give Back After Battling Lymphoma

  Ayden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Schools Join the Fight Against Lymphoma and Blood Cancers

  Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...

• Superheroes Unite For Elementary Student Fighting Lymphoma

  Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...